Purchase Order AG9255P170011
Award Date 8/23/17
Potential Completion Date 9/30/17
Potential Value $25K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02139, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Oxford Nanopore Technologies Inc. was awarded a $8,450 firm fixed-price purchase order by a Southeast Area civilian federal agency for a Spot On Flow Cell MKI (R9.5) component. The contract was awarded on June 5, 2017, with an ultimate completion date of June 22, 2017, and did not utilize a set-aside designation. Performance of the work was to be completed in Gainesville, Florida. As a leading provider of nanopore-based sequencing technologies, Oxford Nanopore Technologies Inc. supplies...
- Oxford Nanopore Technologies Inc. was awarded a $79,026 firm fixed-price purchase order on August 23, 2017, for the delivery of flow cells and sequencing kits to a civilian federal agency in the Southeast Area. The contract, with a completion date of September 1, 2017, was not issued under a set-aside designation. The work will be performed in Gainesville, Florida. Oxford Nanopore Technologies Inc., a foreign-owned biotechnology company specializing in nanopore-based electronic sequencing...
- Oxford Nanopore Technologies Inc. was awarded a $24.6K firm fixed-price purchase order by the Southeast Area civilian agency on September 27, 2019, for a bulk order of 48 flow cells (FLO-MIN106D R9.4 model). The contract, which is not associated with a set-aside designation, was completed by September 30, 2019, with performance occurring in Stoneville, Mississippi. Flow cells are consumable components essential to Oxford Nanopore's nanopore sequencing platforms, enabling researchers to conduct...
- Oxford Nanopore Technologies Inc. was awarded a $47,960 firm fixed-price purchase order by a civilian federal agency (Midwest Area) on December 6, 2019, for genomic sequencing consumables and reagents. The contract, which was set aside for total small business, called for the delivery of MinION flow cells (FLO-MIN 106D R9 and FLO-MIN 110 R10 models) and ligation sequencing kits (SQK-LSK109), with an ultimate completion date of December 20, 2019. The place of performance was Cambridge, MA, and...
- Oxford Nanopore Technologies Inc. received a firm fixed-price purchase order from a civilian federal agency with a Midwest Area office on August 25, 2018, for nanopore DNA sequencing kits, training, and flow cells with a ceiling value of $7.1K. The contract was completed by September 24, 2018, with performance undertaken in Columbia, Missouri. No set-aside designation was applied to this award. Oxford Nanopore Technologies Inc., a foreign-owned biotechnology company specializing in...
- This is a $161,638 firm-fixed-price purchase order awarded by the Northeast Area division of a civilian federal agency to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the delivery of ROSEN - Oxford Nanopore FLO-PRO002 Promethion Flow Cell Packs, which are consumable supplies for Oxford Nanopore's PromethION DNA/RNA sequencing platform. The contract has a completion date of September 14, 2022 and does not have a set-aside designation....
- Oxford Nanopore Technologies Inc. received a $95,605 firm fixed-price purchase order (Contract #GRD-CAPEX) from a civilian Southeast Area federal agency for genomic sequencing equipment and services, with performance in Cambridge, Massachusetts. The contract was awarded on September 5, 2019, with an ultimate completion date of October 4, 2019. This award was not associated with a small business set-aside designation. Oxford Nanopore Technologies Inc., a foreign-owned biotechnology firm...
- This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, was made by the National Institute for Minority Health and Health Disparities, a civilian agency. The $16,500.00 firm fixed-price purchase order is for the delivery of OXFORD NANOPORE TECHNOLOGIES, INC.; FLOW CELL R9 4.1 products by December 31, 2023. This contract does not have a set-aside designation. Oxford Nanopore Technologies Inc. is a provider of next-generation genomic...
- Oxford Nanopore Technologies Inc. was awarded a firm fixed price purchase order valued at $9,480 on March 18, 2016, for a FLO-MAP 103.12 Minion Flow Cell. The contract was funded by a civilian federal agency within the Southeast Area and does not utilize a set-aside designation. Performance is scheduled to conclude by June 30, 2016, with the place of performance in Cambridge, MA. The Minion Flow Cell is a consumable component essential to Oxford Nanopore's portable nanopore sequencing devices,...
- The U.S. Defense agency, the Bureau of Medicine and Surgery, awarded a $80,045.00 firm-fixed-price purchase order contract to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract, identified as N3239824P0044, is for the delivery of P2 INTEGRATED CAPEX and has an ultimate completion date of September 29, 2025. Oxford Nanopore Technologies provides next-generation genomic sequencing equipment, consumables, and associated services to various U.S....